Can C-reactive protein, procalcitonin and mid-regional pro-atrial natriuretic peptide measurements guide choice of in-patient or out-patient care in acute pyelonephritis? Biomarkers In Sepsis (BIS) multicentre study

Clinical Microbiology and Infection

Volumn 16, Issue 6, 2010, Pages 753-760

  Claessens, Y E ^a   Schmidt, J ^b   Batard, E ^c   Grabar, S ^a   Jegou, D ^a   Hausfater, P ^d   Kierzek, G ^e   Guerin S ^a   Pourriat, J L ^e   Dhainaut, J F ^a   Ginsburg, C ^a  

^a Institut Cochin   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

^c HÔTEL DIEU   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; C REACTIVE PROTEIN; PROCALCITONIN;

ACCURACY; ACUTE PYELONEPHRITIS; ADULT; ARTICLE; CLINICAL DECISION MAKING; CONTROLLED STUDY; DISEASE MARKER; EMERGENCY CARE; FEMALE; FOLLOW UP; FRANCE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT CARE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 77953947773     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02955.x     Document Type: Article

References (21)

1. Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis 2007, 45:273-280.
2. Foxman B, Klemstine KL, Brown PD. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol 2003, 13:144-150.
3. Warren J, Abrutyn E, Hebel J, Johnson J, Schaeffer A, Stamm W. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999, 29:745-758.
4. Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, Stamm WE. Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med 2005, 142:20-27.
5. Elkharrat D, Chastang C, Boudiaf M, Le Corre A, Raskine L, Caulin C. Relevance in the emergency department of a decisional algorithm for outpatient care of women with acute pyelonephritis. Eur J Emerg Med 1999, 6:15-20.
6. Almirall J, Bolibar I, Toran P. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 2004, 125:1335-1342. Community-Acquired Pneumonia Maresme Study Group
7. Smith RP, Lipworth BJ. C-reactive protein in simple community-acquired pneumonia. Chest 1995, 107:1028-1031.
8. Korppi M, Heiskanen-Kosma T, Leinonen M. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children. Eur Respir J 1997, 10:1125-1129.
9. Christ-Crain M, Jaccard-Stolz D, Bingisser R. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004, 36:3600-3607.
10. Hausfater P, Garric S, Ayed SB, Rosenheim M, Bernard M, Riou B. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis 2002, 34:895-901.
11. Morgenthaler NG, Struck J, Christ-Crain M, Bergmann A, Muller B. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care 2005, 9:R37-R45.
12. Benador N, Siegrist CA, Gendrel D. Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics 1998, 102:1422-1425.
13. Pecile P, Miorin E, Romanello C. Procalcitonin: a marker of severity of acute pyelonephritis among children. Pediatrics 2004, 114:e249-e254.
14. Lemiale V, Renaud B, Moutereau S. A single procalcitonin level does not predict adverse outcomes of women with pyelonephritis. Eur Urol 2007, 51:1394-1401.
15. Bone RC, Balk RA, Cerra FB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655.
16. Bossuyt PM, Reitsma JB, Bruns DE. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 2003, 138:40-44.
17. Irwig L, Bossuyt P, Glasziou P, Gatsonis C, Lijmer J. Designing studies to ensure that estimates of test accuracy are transferable. BMJ 2002, 324:669-671.
18. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ 2004, 329:168-169.
19. Martinot M, Hansmann Y, De Martino S. [Procalcitonin in pyelonephritis and acute community-acquired pneumonia in adults]. Presse Med 2001, 30:1091-1096.
20. Piccoli BG, Cresto E, Ragni F, Veglio V, Scarpa RM, Frascisco M. The clinical spectrum of acute 'uncomplicated' pyelonephritis from an emergency medicine perspective. Int J Antimicrob Agents 2008, 31:S46-S53.
21. Rollino C, Boero R, Ferro M. Acute pyelonephritis: analysis of 52 cases. Ren Fail 2002, 24:601-608.